These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 34078439)

  • 41. The oncogenic roles of GPR176 in ovarian cancer: a molecular target for aggressiveness and gene therapy.
    Yang N; Yun WJ; Cui ZG; Zheng HC
    J Obstet Gynaecol; 2024 Dec; 44(1):2347430. PubMed ID: 38835234
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ARRDC3 as a Diagnostic and Prognostic Biomarker for Epithelial Ovarian Cancer Based on Data Mining.
    Chen Y; Tian D; Chen X; Tang Z; Li K; Huang Z; Fu Y; Feng Y; Yang Z
    Int J Gen Med; 2021; 14():967-981. PubMed ID: 33790626
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
    Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
    Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of SOCS family members with prognostic values in human ovarian cancer.
    Yang M; Chen H; Zhou L; Huang X; Su F; Wang P
    Am J Transl Res; 2020; 12(5):1824-1838. PubMed ID: 32509179
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and analysis of genes associated with epithelial ovarian cancer by integrated bioinformatics methods.
    Gui T; Yao C; Jia B; Shen K
    PLoS One; 2021; 16(6):e0253136. PubMed ID: 34143800
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of candidate biomarkers and analysis of prognostic values in ovarian cancer by integrated bioinformatics analysis.
    Xu Z; Zhou Y; Cao Y; Dinh TL; Wan J; Zhao M
    Med Oncol; 2016 Nov; 33(11):130. PubMed ID: 27757782
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analyzing the impact of ATF3 in tumorigenesis and immune cell infiltration of ovarian tumor: a bioinformatics study.
    Li X; Liu P; Sun X; Ma R; Cui T; Wang T; Bai Y; Li Y; Wu X; Feng X
    Med Oncol; 2021 Jul; 38(8):91. PubMed ID: 34216322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integrative bioinformatics and experimental analysis revealed TEAD as novel prognostic target for hepatocellular carcinoma and its roles in ferroptosis regulation.
    Ren X; Wang X; Yan Y; Chen X; Cai Y; Liang Q; Peng B; Xu Z; He Q; Kang F; Li J; Zhang W; Hong Q; Peng J; Xiao M
    Aging (Albany NY); 2022 Jan; 14(2):961-974. PubMed ID: 35077390
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of key genes and biological pathways in lung adenocarcinoma via bioinformatics analysis.
    Wang Y; Zhou Z; Chen L; Li Y; Zhou Z; Chu X
    Mol Cell Biochem; 2021 Feb; 476(2):931-939. PubMed ID: 33130972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of Novel Biomarkers Associated With the Prognosis and Potential Pathogenesis of Breast Cancer via Integrated Bioinformatics Analysis.
    Wu M; Li Q; Wang H
    Technol Cancer Res Treat; 2021; 20():1533033821992081. PubMed ID: 33550915
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
    Wu JR; Zhao Y; Zhou XP; Qin X
    Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comprehensive Analysis of Candidate Diagnostic and Prognostic Biomarkers Associated with Lung Adenocarcinoma.
    Li J; Liu X; Cui Z; Han G
    Med Sci Monit; 2020 Jun; 26():e922070. PubMed ID: 32578582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of metastasis and prognosis-associated genes for serous ovarian cancer.
    Yang Y; Qi S; Shi C; Han X; Yu J; Zhang L; Qin S; Gao Y
    Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32510146
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comprehensive analysis of LASS6 expression and prognostic value in ovarian cancer.
    Xing J; Yi J
    J Ovarian Res; 2021 Sep; 14(1):117. PubMed ID: 34488809
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of pathological grade and prognosis-associated lncRNA for ovarian cancer.
    Chen Y; Bi F; An Y; Yang Q
    J Cell Biochem; 2019 Sep; 120(9):14444-14454. PubMed ID: 31034644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Identification of Prognostic Biomarkers Among FAM83 Family Genes in Human Ovarian Cancer Through Bioinformatic Analysis and Experimental Verification.
    Lin S; Du J; Hao J; Luo X; Wu H; Zhang H; Zhao X; Xu L; Wang B
    Cancer Manag Res; 2021; 13():8611-8627. PubMed ID: 34815715
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Bioinformatics Analysis Identifies the Estrogen Receptor 1 (ESR1) Gene and hsa-miR-26a-5p as Potential Prognostic Biomarkers in Patients with Intrahepatic Cholangiocarcinoma.
    Qin X; Song Y
    Med Sci Monit; 2020 May; 26():e921815. PubMed ID: 32435051
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification and Analysis of Key Genes Driving Gastric Cancer Through Bioinformatics.
    Liu Z; Liu S; Guo J; Sun L; Wang S; Wang Y; Qiu W; Lv J
    Genet Test Mol Biomarkers; 2021 Jan; 25(1):1-11. PubMed ID: 33470887
    [No Abstract]   [Full Text] [Related]  

  • 59. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
    Zhao Q; Fan C
    BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gene expression profiling of ovarian carcinomas and prognostic analysis of outcome.
    Cai SY; Yang T; Chen Y; Wang JW; Li L; Xu MJ
    J Ovarian Res; 2015 Jul; 8():50. PubMed ID: 26228058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.